Fig. 2From: A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medicationsPatented medicines for noncommunicable diseases on the WHO EML, 2011-2019. The number above each bar reflects either the total number of medicines or the number of medicines with active medicines on the EML for the year listedBack to article page